Bio-Rad Laboratories (BIO) Non-Current Deffered Revenue (2015 - 2016)
Bio-Rad Laboratories (BIO) posted quarterly Non-Current Deffered Revenue of $4.4 million for Q3 2016, up 17.55% quarter-over-quarter from $3.7 million in Q4 2015.
Bio-Rad Laboratories (BIO) Non-Current Deffered Revenue (2015 - 2016) Analysis & Trends
Bio-Rad Laboratories (BIO) has reported Non-Current Deffered Revenue for 2 consecutive years, with $4.4 million the latest figure, recorded in Q3 2016.
- In Q3 2016, Non-Current Deffered Revenue changed N/A year-over-year to $4.4 million; the TTM figure through Sep 2016 stood at $4.4 million (changed N/A YoY), while the FY2015 annual figure was $3.7 million, changed N/A from the prior year.
- Non-Current Deffered Revenue grew to $4.4 million in Q3 2016 per BIO's latest filing, from $3.7 million in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $4.4 million in Q3 2016 and bottomed at $3.7 million in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | - |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | - |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 539.34 Mn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | - |
| 10 | Bio-Rad Laboratories | 10.10 Bn | 8.49 Bn | 345.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | 4.40 Mn |
| Dec 31, 2015 | 3.74 Mn |